Levetiracetam Puren

Levetiracetam, the active ingredient in Levetiracetam Puren, is a Anticonvulsant presented as an oral tablet for Oral use. It is used to control partial, generalized tonic‑clonic and myoclonic seizures in patients with epilepsy. GNH USA supplies Levetiracetam Puren as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic drug that reduces abnormal neuronal firing in the brain. - Partial seizures: helps achieve seizure freedom or significant reduction in seizure frequency. - Generalized tonic‑clonic seizures: contributes to control of convulsive episodes across the patient population. - Myoclonic seizures: diminishes rapid muscle jerks and improves daily functioning.

Levetiracetam may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Fatigue: persistent feeling of tiredness. - Headache: mild to moderate cranial pain. - Irritability: increased emotional sensitivity. - Nausea: upset stomach or urge to vomit. - Nasal congestion: blocked or runny nose.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Mood changes: depression, anxiety, or suicidal thoughts. - Blood disorders: low white blood cells or platelets. - Liver enzyme elevation: abnormal liver function tests. - Skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before initiating therapy, consider the following safety measures. - Renal function: adjust dose in patients with impaired kidney function. - Psychiatric history: monitor for mood alterations or suicidal ideation. - Concomitant CNS depressants: assess additive sedation risk. - Pregnancy: discuss potential risks as safety data are limited. - Lactation: evaluate infant exposure through breast milk. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Levetiracetam can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenobarbital: can lower levetiracetam exposure.

Moderate Interactions (Monitor Closely): - Alcohol: may increase central nervous system depression. - Other antiepileptics (e.g., valproate, phenytoin): monitor seizure control and side‑effect profile. - Oral contraceptives: potential reduction in hormonal efficacy; consider alternative contraception.